Mutsuki Takano Appointed as Executive Officer, CFO/ COO of BionicM Inc.

BionicM Inc. (Headquarters: Bunkyo-ku, Tokyo; President & CEO: Xiaojun Sun; hereinafter "BionicM") is pleased to announce the appointment of Mutsuki Takano as Chief Financial Officer (CFO) / Chief Operating Officer (COO).

Mutsuki Takano developed a global business mindset at Mitsui & Co., Ltd., one of Japan’s leading international trading companies, where he was involved in business operations, creation, and expansion across diverse regions including Japan, the U.S., the U.K., China, India, and other Asian countries. In the biotech sector, he has contributed to enhancing the corporate value of drug discovery ventures through various roles, including venture capital investment, support for portfolio companies, and serving as CFO for a regenerative medicine biotech firm. To date, he has successfully led equity financing totaling approximately 15 billion Japanese Yen.

In his previous role as Board Director and CFO of Heartseed Inc., a company developing cardiomyocyte regenerative therapy for advanced heart failure patients, he led the company to a successful IPO on the Tokyo Stock Exchange Growth Market in July 2024. In recognition of these achievements, he was named one of the "Most Innovative CFOs from Asia to Watch in 2024" by CXO Magazine.

Comment from Xiaojun Sun, Founder & CEO:

"I am delighted to welcome Mutsuki Takano to BionicM as our CFO/COO. I look forward to his contributions to our mission, 'Powering Mobility for All,' by leveraging his extensive and diverse experience."

Comment from Mutsuki Takano:

"I am honored to contribute to the aspirations of lower-limb amputees worldwide who need better prosthetics, under the leadership of CEO Sun, who has transformed his own research into reality from a user’s perspective as a powered prosthetic user himself. As a member of BionicM, I will do my utmost to grow the company into an innovative leader in the Healthcare x Robotics x AI sectors and deliver significant value to all our stakeholders."

About BionicM Inc, :

Founded in 2018 as a spin-off from the University of Tokyo, BionicM emerged from the innovative research and development spearheaded by Sunny Xiaojun Sun during his doctoral studies at the University of Tokyo, under the mentorship of Professor Inaba (currently Professor Emeritus). Supported by JST's START program, BionicM leverages advanced humanoid robotics technology to develop and market powered microprocessor knees. As a global startup, BionicM is driven by its mission to "Power Mobility for All," with a focus on enhancing mobility and improving the quality of life (QOL) for individuals with lower-limb amputations. Through cutting-edge technology and a commitment to innovation, BionicM aims to provide transformative solutions that empower users to lead more active and fulfilling lives.

_____________________________________

Press and Investor Contact:

Mutsuki Takano, CFO/COO

Tel: +81-3-3868-2679, EMAIL: press@bionicm.com

203 The University of Tokyo Entrepreneur Plaza, 7-3-1 Hongo Bunkyo-ku, Tokyo, Japan